ロード中...
Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study
BACKGROUND: One of the reasons why Isoniazid preventive therapy (IPT) for Tuberculosis (TB) is not widely used in low income countries is concerns on cost of excluding active TB. We analyzed the cost-effectiveness of IPT provision in Tanzania having ruled out active TB by a symptom-based screening t...
保存先:
| 出版年: | BMC Public Health |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5518094/ https://ncbi.nlm.nih.gov/pubmed/28724374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12889-017-4597-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|